Establishment of an induced pluripotent stem cell line SDQLCHi048-A from a healthy boy donor

Ziwen Feng1, Xiaomeng Yang2, Jingyun Guan2

  • 1Pediatric Research Institute, Children's Hospital Affiliated to Shandong University, Ji'nan 250022, China; Shandong University of Traditional Chinese Medicine, Ji'nan 250355, China; Tumor Minimally Invasive Comprehensive Treatment Department, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Ji'nan 250021, China.

Stem Cell Research
|May 25, 2023
PubMed

Insights

A new induced pluripotent stem cell (iPSC) line, SDQLCHi048-A, was created from a healthy boy's blood cells. This versatile cell line shows pluripotency and differentiation potential, useful for disease research.

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine
  • Genetics

Background:

  • Induced pluripotent stem cells (iPSCs) offer a powerful tool for disease modeling and personalized medicine.
  • Generating well-characterized iPSC lines is crucial for advancing research in these fields.

Purpose of the Study:

  • To report the generation and characterization of a novel human iPSC line, designated SDQLCHi048-A.
  • To assess the pluripotency and differentiation capacity of the newly derived iPSC line.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from a healthy infant were reprogrammed to generate iPSCs.
  • Characterization involved assessing pluripotency marker expression, confirming episomal vector clearance, and performing karyotyping.
  • In vitro trilineage differentiation potential was evaluated.

Main Results:

  • The iPSC line SDQLCHi048-A successfully expressed key pluripotency markers.
  • Analysis confirmed the absence of episomal vectors and a normal karyotype.
  • The iPSC line demonstrated the capacity for differentiation into all three germ layers in vitro.

Conclusions:

  • The established iPSC line SDQLCHi048-A is a valuable resource for stem cell research.
  • This cell line provides a foundation for studying disease mechanisms and molecular pathogenesis.